Home » BioMarin Treatment Gets Special FDA Status
BioMarin Treatment Gets Special FDA Status
BioMarin Pharmaceutical Inc. said Monday the Food and Drug Administration granted orphan drug
designation to a developing treatment for a rare autoimmune disorder.
CNBC
CNBC
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May